DermTech, Inc. (DMTK)
NASDAQ: DMTK · IEX Real-Time Price · USD
3.65
+0.30 (8.96%)
At close:
Mar 29, 2023, 4:00 PM
3.75
+0.10 (2.74%)
After-hours:
Mar 29, 2023, 6:22 PM EDT
Stock Price Forecast
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for DermTech stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 5 | 5 | 5 | 5 |
Buy | 6 | 6 | 6 | 6 | 6 | 6 |
Hold | 1 | 1 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 13 | 13 | 13 | 13 | 13 |
Financial Forecast
Revenue This Year
19.69M
from 14.52M
Increased by
35.63%
Revenue Next Year
42.45M
from 19.69M
Increased by
115.58%
EPS This Year
-3.65
from -3.88
EPS Next Year
-3.11
from -3.65
Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Revenue | 2.44M | 3.36M | 5.89M | 11.84M | 14.52M | 19.69M | 42.45M | 88.18M |
Revenue Growth | - | 37.76% | 74.94% | 101.16% | 22.64% | 35.63% | 115.58% | 107.72% |
EPS | -2.27 | -2.87 | -2.15 | -2.71 | -3.88 | -3.65 | -3.11 | -2.55 |
EPS Growth | - | - | - | - | - | - | - | - |
No. Analysts | - | - | - | - | - | 9 | 9 | 5 |
Revenue Forecast
Revenue | 2023 | 2024 | 2025 |
---|---|---|---|
High | 26.3M | 112.7M | 189.8M |
Avg | 19.7M | 42.5M | 88.2M |
Low | 13.7M | 20.4M | 39.7M |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | 80.8%
| 472.2%
| 347.2%
|
Avg | 35.6%
| 115.6%
| 107.7%
|
Low | -5.5%
| 3.5%
| -6.5%
|
EPS Forecast
EPS | 2023 | 2024 | 2025 |
---|---|---|---|
High | -3.21 | -1.60 | -1.84 |
Avg | -3.65 | -3.11 | -2.55 |
Low | -3.76 | -3.66 | -2.87 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.